Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...

Early-life mutagenic exposure to colibactin-producing bacteria may be associated with the increased incidence of early-onset colorectal cancer.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD).

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Patients with vs without RA have a higher risk for avoidable hospitalizations for ambulatory care sensitive conditions, particularly heart failure and pulmonary edema.

Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.

This patient perspectives interview features Stacy Courtnay, who shared her experience managing rheumatoid arthritis during ...

Ultrasound-guided minimally invasive tenosynovial biopsy is a feasible, safe, and well-tolerated technique among patients with different stages of RA.

Hospital-onset antimicrobial-resistant infections increased across US hospitals during and beyond the COVID-19 pandemic.

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.